• SENSEX
    NIFTY 50
Politics

Trump administration signs up new company to make COVID-19 drugs in US

Updated : May 20, 2020 08:26 AM IST

The administration has been looking to build up the ability to produce drugs and their raw materials in the United States after the global pandemic exposed the industry's dependence on China and India for its supply chain.
The US Department of Health and Human Services said it had awarded a four-year, $354 million contract to privately-held Phlow Corp to make COVID-19 drugs, other essential drugs and their ingredients.
Phlow, which was incorporated in January, said the contract will help it contribute to a national stockpile of pharmaceutical ingredients for essential medicines.
Trump administration signs up new company to make COVID-19 drugs in US

You May Also Like

Live TV
Advertisement